Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Treatment Protocol to Provide Continued ACH-126,443 to Subjects of Previous Achillion-Sponsored Phase 1 and 2 Studies in Chronic Hepatitis B Infection

NCT00037622 is registered in ClinicalTrials.gov with Alexion Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00037622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Treatment Protocol to Provide Continued ACH-126,443 to Subjects of Previous Achillion-Sponsored Phase 1 and 2 Studies in Chronic Hepatitis B Infection
Lead sponsor
Alexion Pharmaceuticals, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
Not reported
Completion date
May 31, 2003
Enrollment
100
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b